These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2557804)
1. The effect of pentostam and cimetidine on the development of leishmaniasis (Leishmania mexicana amazonensis) and concomitant malaria (Plasmodium yoelii). Coleman RE; Edman JD; Semprevivo LH Ann Trop Med Parasitol; 1989 Aug; 83(4):339-44. PubMed ID: 2557804 [TBL] [Abstract][Full Text] [Related]
2. Interactions between Plasmodium yoelii and Leishmania mexicana amazonensis in Leishmania resistant C57B1/6 mice. Coleman RE; Edman JD; Semprevivo LH Am J Trop Med Hyg; 1988 Dec; 39(6):540-4. PubMed ID: 3207174 [TBL] [Abstract][Full Text] [Related]
3. Leishmania mexicana: effect of concomitant malaria on cutaneous leishmaniasis. Development of lesions in a Leishmania-susceptible (BALB/c) strain of mouse. Coleman RE; Edman JD; Semprevivo LH Exp Parasitol; 1988 Apr; 65(2):269-76. PubMed ID: 3350106 [TBL] [Abstract][Full Text] [Related]
4. Interactions between malaria (Plasmodium yoelii) and leishmaniasis (Leishmania mexicana amazonensis): effect of concomitant infection on host activity, host body temperature, and vector engorgement success. Coleman RE; Edman JD; Semprevivo LH J Med Entomol; 1988 Nov; 25(6):467-71. PubMed ID: 3204626 [No Abstract] [Full Text] [Related]
5. Effect of cimetidine and 2'-deoxyguanosine on the development of Leishmania mexicana in Balb/C mice. Coleman RE; Edman JD; Semprevivo LH Trans R Soc Trop Med Hyg; 1988; 82(2):232-3. PubMed ID: 2847375 [No Abstract] [Full Text] [Related]
6. Metastasis of Leishmania mexicana in a Leishmania-resistant mouse strain (C/57) following concomitant malarial infection. Coleman RE; Edman JD; Semprevivo LH Ann Trop Med Parasitol; 1988 Aug; 82(4):399-401. PubMed ID: 3252763 [No Abstract] [Full Text] [Related]
8. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species. Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571 [TBL] [Abstract][Full Text] [Related]
9. Malaria-Cutaneous Leishmaniasis Co-infection: Influence on Disease Outcomes and Immune Response. Pinna RA; Silva-Dos-Santos D; Perce-da-Silva DS; Oliveira-Ferreira J; Villa-Verde DM; De Luca PM; Banic DM Front Microbiol; 2016; 7():982. PubMed ID: 27446022 [TBL] [Abstract][Full Text] [Related]
10. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. Padigel UM; Alexander J; Farrell JP J Immunol; 2003 Oct; 171(7):3705-10. PubMed ID: 14500669 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of some drugs on Leishmania donovani in the golden hamster, Mesocricetus auratus. Al-Khateeb GH; Molan AL Chemotherapy; 1981; 27(2):117-25. PubMed ID: 6110518 [TBL] [Abstract][Full Text] [Related]
12. Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure. Grögl M; Oduola AM; Cordero LD; Kyle DE Exp Parasitol; 1989 Jul; 69(1):78-90. PubMed ID: 2543590 [TBL] [Abstract][Full Text] [Related]
13. Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis. Murray HW; Oca MJ; Granger AM; Schreiber RD J Clin Invest; 1989 Apr; 83(4):1253-7. PubMed ID: 2539396 [TBL] [Abstract][Full Text] [Related]
14. Ivermectin, levamisole and thymic extract for chemotherapy and immunostimulation of visceral leishmaniasis in hamsters and mice. Rifaat LK; Mohammad MA; Jawdat SZ Jpn J Med Sci Biol; 1989 Apr; 42(2):51-61. PubMed ID: 2561164 [TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections. Alexander J; Kaye PM Clin Exp Immunol; 1985 Sep; 61(3):674-82. PubMed ID: 3907906 [TBL] [Abstract][Full Text] [Related]
16. In vivo near-infrared fluorescence imaging of Leishmania amazonensis expressing infrared fluorescence protein (iRFP) for real-time monitoring of cutaneous leishmaniasis in mice. Oliveira JC; da Silva AC; Oliveira RA; Pereira VR; Gil LH J Microbiol Methods; 2016 Nov; 130():189-195. PubMed ID: 27498229 [TBL] [Abstract][Full Text] [Related]
17. A standardized intraperitoneal Glucantime™ for experimental treatment of cutaneous leishmaniasis caused by Leishmania amazonensis in BALB/c mice. Brustolin AÁ; Franzói NM; Ramos-Milaré ÁCFH; Tanoshi CA; Mota CA; Demarchi IG; Lonardoni MVC; Verzignassi Silveira TG Exp Parasitol; 2022; 236-237():108259. PubMed ID: 35427563 [TBL] [Abstract][Full Text] [Related]
18. Leishmania amazonensis: Increase in ecto-ATPase activity and parasite burden of vinblastine-resistant protozoa. Giarola NL; Silveira TS; Inacio JD; Vieira LP; Almeida-Amaral EE; Meyer-Fernandes JR Exp Parasitol; 2014 Nov; 146():25-33. PubMed ID: 25176449 [TBL] [Abstract][Full Text] [Related]
19. Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam). Berman JD; Grogl M Exp Parasitol; 1988 Oct; 67(1):96-103. PubMed ID: 2844580 [TBL] [Abstract][Full Text] [Related]
20. Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge. Chávez-Fumagalli MA; Costa MA; Oliveira DM; Ramírez L; Costa LE; Duarte MC; Martins VT; Oliveira JS; Olortegi CC; Bonay P; Alonso C; Tavares CA; Soto M; Coelho EA Microbes Infect; 2010 Nov; 12(12-13):967-77. PubMed ID: 20601076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]